Skip to content
Main Navigation
Mercia
Looking for investment?
Investors
Team
Portfolio
Hub
Portfolio resources
ESG
Nucleus
About us
Our story
Who we do it for
Our history
University partners
Funds we manage
Working at Mercia
Newsletter
Sign up
Looking for investment?
Investors
Team
Portfolio
Hub
Portfolio resources
ESG
Nucleus
About us
Our story
Who we do it for
Our history
University partners
Funds we manage
Working at Mercia
Newsletter
Sign up
News
All Fund types
All funds
CBILS
Coalfields Funds
Direct Investments
EV Growth Fund
Finance Yorkshire Business Loans
Finance Yorkshire Seedcorn Fund
Future Fund
MEIF – Proof of Concept
MEIF II Equity – East and South East Midlands
MEIF II Equity – West Midlands
Mercia EIS Funds
Mercia SEIS
MF1
North East Venture Fund
Northern VCTs
NPIF Debt
NPIF Equity
Private Equity
RisingStars
SME Health Innovation Fund
SME Loans
The North West Fund for Mezzanine
The North West Fund for Venture Capital
All Sectors
Digital & Digital Entertainment
Electronics, Materials, Manufacturing/Engineering
FDC
Life Sciences & Biosciences
Mercia Board
Mercia Debt
Mercia Operations
Mercia Private Equity
Mercia Ventures
Other
Software & E-commerce
Software & the Internet
VCT Board
Clear filters
Mercia EIS Funds | 7th February, 2014
IFA Magazine – EIS investment is on the rise, but where is the capital being allocated?
Mercia EIS Funds | 3rd February, 2014
IFA Magazine – High Returns Don’t Always Mean High Risk
Mercia EIS Funds | 31st January, 2014
MFM featured in Growth Business on the need to increase the SEIS threshold
Mercia EIS Funds | 19th December, 2013
Mercia Growth Fund 3 announced – the latest hybrid EIS/SEIS investment fund from Mercia Fund Management
Mercia EIS Funds | 18th December, 2013
MFM mentioned in FT on why crowdfunding isn’t right for many start-ups
Mercia EIS Funds | 4th December, 2013
Simon Cartmell, healthcare expert and ex CEO of ApaTech, joins Mercia Fund Management Investment Panel
Mercia EIS Funds | 29th November, 2013
Autumn statement 2013: raise the seed funding cap or SMEs won’t flourish
Mercia EIS Funds | 27th November, 2013
Warwick Audio secures £1.25 million investment package
Mercia EIS Funds | 26th November, 2013
Kwanji successfully closes initial seed funding round led by MFM
Mercia EIS Funds | 12th November, 2013
Mid-Stage Clinical Study of Wasting Disease Therapeutic MT-102 Shows Reversal of Cancer-Related Wasting
Mercia EIS Funds | 30th October, 2013
Mercia Fund Management holds Open House for companies seeking investment
Mercia EIS Funds | 25th October, 2013
Drug discovery services company CYP Design Ltd completes seed funding round
Mercia EIS Funds | 23rd October, 2013
Mercia Fund Management appoints Sales and Investor Relations Manager – Talon Golding
Mercia EIS Funds | 3rd October, 2013
PsiOxus Therapeutics named EuropaBio’s Most Innovative European Biotech SME
Mercia EIS Funds | 1st October, 2013
World First: The Native Antigen Company succeeds in manufacturing all four DENV NS1 serotypes from human cell lines
Mercia EIS Funds | 30th September, 2013
Mercia Fund Management makes first digital sector investment with Metric
Mercia EIS Funds | 18th September, 2013
Mercia Fund Management announces Mike Hayes as head of new digital division
Mercia EIS Funds | 21st August, 2013
Smart Antenna Technologies brings single antenna solution to cellular handsets
Mercia EIS Funds | 31st July, 2013
Antitope Announces Research Agreement with ChemomAb for Generation of Composite Human Antibodies against Inflammatory Diseases
Mercia EIS Funds | 29th July, 2013
Mercia Fund Management makes investment to help accelerate the growth of PolyTherics
Mercia EIS Funds | 24th July, 2013
Oxford Genetics secures funding for DNA cloning system
Mercia EIS Funds | 26th June, 2013
How Mercia Fund Management funds University of Keele spin-outs
Mercia EIS Funds | 24th June, 2013
PsiOxus Therapeutics initiates second clinical study of oncolytic vaccine
Mercia EIS Funds | 18th June, 2013
Ventive named national runner up in Shell Springboard awards 2013
Mercia EIS Funds | 23rd May, 2013
Irresistible Materials secures funding boost and new Chairman
Mercia EIS Funds | 9th May, 2013
Shell Springboard regional winner Ventive secures £900,000 funding
Mercia EIS Funds | 8th May, 2013
Dr Christine Wilkinson Blanc joins Psioxus Therapeutics as Chief Medical Officer
Mercia EIS Funds | 15th April, 2013
Mercia Fund Management announces Carlton Jones as nanoTherics’ CEO
Mercia EIS Funds | 9th April, 2013
Mercia Fund Management announces first SEIS investments from the Mercia Growth Fund 1
Mercia EIS Funds | 4th April, 2013
Oxford’s Native Antigen Company receives funding boost
Mercia EIS Funds | 27th March, 2013
Mercia Fund Management announces its first EIS investments from Mercia Growth Fund 1
Mercia EIS Funds | 25th March, 2013
Why SEIS is particularly attractive for 2013/14
Mercia EIS Funds | 15th March, 2013
Mercia Fund Management holds first Open House for SEIS and EIS investees
Mercia EIS Funds | 8th March, 2013
PolyTherics receives milestone payment as Celtic Pharma progresses development of long-acting version of Blood Factor VIII produced using PolyTherics’ TheraPEG™ technology
Mercia EIS Funds | 6th March, 2013
Mercia Fund Management launches Mercia Growth Fund 2 – a new hybrid EIS/SEIS investment opportunity
Mercia EIS Funds | 4th March, 2013
PsiOxus Therapeutics completes patient enrolment for Phase II wasting disease therapeutic MT-102
Mercia EIS Funds | 18th February, 2013
Forward Group takes equity stake in Mercia Fund Management
Mercia EIS Funds | 17th January, 2013
DTRA awards US$3.3m contract to psioxus therapeutics to develop biodefence vaccine adjuvants
Mercia EIS Funds | 21st November, 2012
Mercia Fund Management announces over subscription to the SEIS portion of Mercia Growth Fund 1
Mercia EIS Funds | 13th November, 2012
Allinea MAPs Out New Performance Tool
Mercia EIS Funds | 7th November, 2012
National newspapers cover Mercia SEIS Fund
Mercia EIS Funds | 6th November, 2012
Mercia Fund Management highlights combined SEIS and EIS Funds at VCT and EIS Investor Forum
Mercia EIS Funds | 31st October, 2012
UK Government Awards 1.7M Grant To Psioxus Therapeutics For Second Phase I/II Clinical Trial Of Cancer Vaccine
Mercia EIS Funds | 28th October, 2012
Biotecnol and PolyTherics enter into a Research Collaboration for the Development of Tribody Antibody Drug Conjugates
Mercia EIS Funds | 18th October, 2012
Talking about the West Midlands European Regional Development Fund Programme
Mercia EIS Funds | 16th October, 2012
PolyTherics expands collaboration with a top five pharmaceutical company to enhance the clinical properties of biopharmaceuticals using PolyPEG
Mercia EIS Funds | 1st October, 2012
Talking university spin-outs – University of Warwick
Mercia EIS Funds | 26th September, 2012
Psioxus Launches Phase I/II Clinical Trial Of Oncolytic Vaccine With Dosing Of Patient With Metastatic Colorectal Cancer
Mercia EIS Funds | 13th September, 2012
Psioxus Therapeutics converts GBP 1 million in loan notes from the Wellcome Trust
Mercia EIS Funds | 12th September, 2012
Mercia Fund Management congratulates PsiOxus Therapeutics on Best Biotech Fund Raiser award
Mercia EIS Funds | 10th September, 2012
Pro Bono Bio obtains exclusive licence from PolyTherics
Mercia EIS Funds | 6th September, 2012
Looking at university spin-outs: University of Birmingham
Mercia EIS Funds | 21st August, 2012
PolyTherics appoints new head of business development
Mercia EIS Funds | 20th July, 2012
Hybrid SEIS scheme investment fund launched – the Mercia Growth Fund
Mercia EIS Funds | 18th June, 2012
PolyTherics granted further patents for TheraPEG and GlycoPol
Mercia EIS Funds | 17th June, 2012
Allinea DDT the debugger of choice for the worlds most powerful supercomputer.
Mercia EIS Funds | 29th May, 2012
Pro Bono Bio and PolyTherics progress and expand their relationship for the development of improved blood factors
Mercia EIS Funds | 15th May, 2012
New Board Members join PolyTherics
Mercia EIS Funds | 10th May, 2012
Internal Fixation Systems Enters Into a Distribution Agreement With Intelligent Orthopaedics
Mercia EIS Funds | 18th April, 2012
NewNet Investor Profile of Andrew Oldfield Head of Clean Tech at Mercia Fund Management
Mercia EIS Funds | 17th March, 2012
Mercia Fund Management interview with AltAssets
Mercia EIS Funds | 7th March, 2012
STORM from Intelligent Orthopaedics Shown to Reduce Radiation Exposure during tibial fractures surgery
Mercia EIS Funds | 4th March, 2012
EIS schemes in 2012 – what you need to know
Mercia EIS Funds | 1st February, 2012
Smart Antenna Technologies BBC interview
Mercia EIS Funds | 2nd January, 2012
EIS Magazine launches
News | 1st January, 1970
UK medtech company, IBEX, demonstrates the clinical effectiveness of a radical new product
News | 1st January, 1970
WEBINAR: What ESG adds to Mercia’s EIS Funds
News | 1st January, 1970
WEBINAR: OXGENE – An outstanding exit for EIS investors
News | 1st January, 1970
The Panel: Building your finance team for growth
News | 1st January, 1970
#OneMercia
MEIF - Proof of Concept | 1st January, 1970
The software firm using video games to motivate sales staff
News | 1st January, 1970
WEBINAR: Compound interest in EIS funds – The case studies
Northern VCTs | 1st January, 1970
Burda invests £16m in Mercia-backed sustainable food platform
Direct Investments | 1st January, 1970
Completion of the sale of Faradion
NPIF Equity | 1st January, 1970
Medic raises £1.5m for app to help children prepare for surgery
News | 1st January, 1970
Previous
1
2
3
4
5
6
7
8
9
10
11
Loading...
Loading...